New ways to treat nerve pain from diabetes
Targeting methylglyoxal-induced diabetic neuropathic pain through the integrated stress response
This project explores how a chemical byproduct called methylglyoxal contributes to nerve pain in people with diabetes, hoping to find better treatments.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Texas Dallas NIH-funded |
| Lab location | 1 site (Richardson, United States) |
| Project ID | NIH-11145851 on NIH RePORTER |
What this research studies
Many people with diabetes experience chronic nerve pain that is difficult to manage with current medications. This research focuses on a chemical called methylglyoxal (MGO), which is often found at higher levels in individuals with diabetes and is linked to pain. We believe MGO triggers a specific 'stress response' within nerve cells, making them overly sensitive and causing pain signals. Our goal is to understand how this stress response makes nerve cells more excitable and to identify new targets to block this process, potentially leading to more effective pain relief for diabetic patients.
Who could benefit from this research
Good fit: This research is foundational and does not directly recruit patients, but future clinical trials would likely seek individuals with diabetic neuropathic pain.
Not a fit: Patients whose pain is not related to diabetes or the specific biological pathways being studied may not directly benefit from this particular line of research.
Why it matters
Potential benefit: If successful, this research could lead to new medications that specifically target the causes of diabetic nerve pain, offering better relief than current treatments.
How similar studies have performed: Preliminary work in laboratory models has shown promising results, suggesting that targeting this stress response pathway could be a novel approach to treating diabetic nerve pain.
Where this research is happening
Richardson, United States
- University of Texas Dallas — Richardson, United States (Active)
Researchers
- Principal investigator: Yousuf, Muhammad Saad — University of Texas Dallas
- Study coordinator: Yousuf, Muhammad Saad
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.